Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors
2016; Massachusetts Medical Society; Volume: 375; Issue: 12 Linguagem: Inglês
10.1056/nejmoa1607887
ISSN1533-4406
AutoresStuart J. Connolly, Truman J. Milling, John W. Eikelboom, C. Michael Gibson, John T. Curnutte, Alex Gold, Michele Bronson, Genmin Lu, Pamela B. Conley, Peter Verhamme, Jeannot Schmidt, Saskia Middeldorp, Alexander T. Cohen, Jan Beyer‐Westendorf, Pierre Albaladejo, José López‐Sendón, Shelly Goodman, Janet M. Leeds, Brian L. Wiens, Deborah Siegal, Elena Zotova, Brandi Meeks, Juliet Nakamya, W. Ting Lim, Mark Crowther,
Tópico(s)Acute Myocardial Infarction Research
ResumoAndexanet alfa (andexanet) is a recombinant modified human factor Xa decoy protein that has been shown to reverse the inhibition of factor Xa in healthy volunteers.
Referência(s)